( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



*Dr. R. Anil Kumar and Dr Surekha B. Shetty


Background: Diabetes mellitus is a chronic metabolic disorder characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both. It is a major cause of mortality and morbidity worldwide. While evaluating diabetes, C-peptide has been a widely used measure of pancreatic beta cell function. It is produced in equimolar amounts to endogenous insulin but is excreted at a more constant rate over a longer time. The measurement of C-peptide provides a better index of endogenous insulin production and pancreatic beta cell function than insulin measurements. C-peptide level is associated with diabetes type and duration of disease. It is useful for differentiating type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). C-peptide level may also correlate with microvascular and macrovascular complications. It has been proposed as one of the predictors of future use of insulin therapy, as well as likely response to other individual therapies. The current study was conducted to know the utility of c peptide levels in assessing the endogenous insulin secretory function in Indian patients with type 2 diabetes. Methods: The present study was conducted in 150 adult patients of type 2 diabetes mellitus presenting in outpatient department of Karnataka institute of endocrinology and research. Subjects with Type 1 diabetes, pregnant women with diabetes, subjects presenting with acute infections, septicemia, patients with acute or chronic pancreatitis, and subjects with pancreatic carcinoma were excluded from the study. In this study C-Peptide levels were estimated by electro chemiluminescence immunoassay method. Results: 150 type 2 diabetes subjects were selected randomly. Age group <30 to >70 years, 68.7% were males. Family history for diabetes was positive in 58.7% subjects. Duration of diabetes vary between new to > 10 years. 82% of subjects had BMI 18.5 to 30. 58% of subjects had waist circumference 90 to 110 centimeters. 49.3% had HBA1c 6 to 9% and in 49.3% HBA1c was >9%. Fasting C-peptide levels were normal in 20.7% and high in 70.3% of type 2 diabetes subjects. None of the patients fasting C-peptide was less than normal. BMI, waist circumference and triglyceride levels were high in type 2 diabetes subjects with high C-peptide levels. Conclusions: The current clinical role of C-peptide in diabetes is to differentiate type 1 diabetes from type 2 diabetes especially in subjects with overlapping clinical features. There is a limited role in the diagnosis of Type 2 diabetes with marked hyperglycemia where C-peptide testing may support a clinical decision on initial insulin therapy. Routine C-peptide testing in type 2 diabetes with poor glycaemic control can help to decide treatment modalities. It can also help in creating awareness about insulin resistance and need for aggressive lifestyle modification.

Keywords: C-Peptide, HBA1c, triglyceride.

[Full Text Article]




    December issue has been successfully launched on December 2023.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2023 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia